The objective of this systematic review is to evaluate and compare the clinical outcomes of bariatric surgery with those of evidence-based pharmacological treatment regimens, such as metformin, insulin, GLP-1 receptor agonists, and SGLT2 inhibitors, in adults with obesity and T2DM. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.